CRYOFOCUS MEDTECH (SHANGHAI) CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.97 HKD | -1.55% |
|
-10.64% | -62.96% |
| 03-27 | Cryofocus Medtech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-15 | Cryofocus Medtech Gets Marketing Approval in China for Cryoadhesion System | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 3,729 | 1,546 | 1,546 | - |
| Enterprise Value (EV) 1 | 3,729 | 4,090 | 1,546 | 1,546 |
| P/E ratio | - | -41.7 x | -22.7 x | -108 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 137 x | 99.9 x | 9.02 x | 4.41 x |
| EV / Revenue | 137 x | 99.9 x | 9.02 x | 4.41 x |
| EV / EBITDA | - | -39.2 x | -27.4 x | 380 x |
| EV / FCF | - | -18.2 x | -17.7 x | -55.8 x |
| FCF Yield | - | -5.49% | -5.66% | -1.79% |
| Price to Book | - | 10.3 x | 19 x | 22.3 x |
| Nbr of stocks (in thousands) | 239,110 | 239,110 | 239,110 | - |
| Reference price 2 | 15.60 | 6.466 | 6.466 | 6.466 |
| Announcement Date | 23-03-30 | 24-03-27 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | 27.15 | 40.95 | 171.5 | 350.5 |
| EBITDA 1 | - | -104.4 | -56.49 | 4.07 |
| EBIT 1 | - | -105.1 | -71 | -15.15 |
| Operating Margin | - | -256.64% | -41.4% | -4.32% |
| Earnings before Tax (EBT) 1 | - | -105.7 | -71.64 | -15.85 |
| Net income 1 | -112.2 | -97.49 | -67.94 | -15.04 |
| Net margin | -413.36% | -238.06% | -39.62% | -4.29% |
| EPS 2 | - | -0.4100 | -0.2850 | -0.0600 |
| Free Cash Flow 1 | - | -84.95 | -87.44 | -27.72 |
| FCF margin | - | -214.35% | -50.99% | -7.91% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 23-03-30 | 24-03-27 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | -84.9 | -87.4 | -27.7 |
| ROE (net income / shareholders' equity) | - | -48% | -47.2% | -13.1% |
| ROA (Net income/ Total Assets) | - | -36.6% | -30.3% | -6.65% |
| Assets 1 | - | 272 | 224.1 | 226.3 |
| Book Value Per Share 2 | - | 0.6300 | 0.3400 | 0.2900 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 12.4 | 15.9 | 29.7 |
| Capex / Sales | - | 31.39% | 9.28% | 8.48% |
| Announcement Date | 23-03-30 | 24-03-27 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.461
CNY
Average target price
25.57
CNY
Spread / Average Target
+295.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -62.96% | 217M | |
| +37.93% | 705B | |
| +32.82% | 583B | |
| -3.66% | 364B | |
| +20.21% | 332B | |
| +4.95% | 291B | |
| +16.64% | 238B | |
| -4.13% | 210B | |
| +10.63% | 209B | |
| +8.79% | 169B |
- Stock Market
- Equities
- 6922 Stock
- Financials Cryofocus Medtech (Shanghai) Co., Ltd.
